IDEAYA Biosciences (IDYA) FCF Margin (2020 - 2026)

IDEAYA Biosciences has disclosed FCF Margin across 7 years of filings, most recently posting 1160.62% for Q1 2026.

• FCF Margin for Q1 2026 came in at 1160.62%, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was 38.15% (changed N/A YoY), and the FY2025 annual result was 33.59%, up 352445.0% from the prior year.
• FCF Margin came in at 1160.62% for Q1 2026 at IDEAYA Biosciences, down from 848.06% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 69.08% in Q3 2025 to a low of 1719.7% in Q4 2024.
• The 5-year median for FCF Margin is 443.95% (2022), against an average of 594.45%.
• Across the five-year window, FCF Margin sank 109283 bps in 2024 and surged 87164 bps in 2025, its largest moves.
• IDEAYA Biosciences' FCF Margin stood at 505.0% in 2022, then declined by 24 bps to 626.87% in 2023, then plunged by 174 bps to 1719.7% in 2024, then soared by 51 bps to 848.06% in 2025, then tumbled by 37 bps to 1160.62% in 2026.
• The last three FCF Margin figures came in at 1160.62% (Q1 2026), 848.06% (Q4 2025), and 69.08% (Q3 2025), per Business Quant data.